- Author:
Li ZHANG
1
;
Yao ZOU
1
;
Xiao-Fei AI
1
;
Zeng CAO
1
;
Yu-Mei CHEN
1
;
Ye GUO
1
;
Wen-Yu YANG
1
;
Xiao-Juan CHEN
1
;
Shu-Chun WANG
1
;
Xiao-Ming LIU
1
;
Min RUAN
1
;
Tian-Feng LIU
1
;
Fang LIU
1
;
Ben-Quan QI
1
;
Li-Xian CHANG
1
;
Wen-Bin AN
1
;
Yuan-Yuan REN
1
;
Qing-Hua LI
1
;
Xiao-Fan ZHU
2
Author Information
- Publication Type:Journal Article
- MeSH: Adolescent; Bone Marrow; Child; Child, Preschool; Female; Humans; Male; Neoplasm, Residual; Oncogene Proteins, Fusion/genetics*; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Recurrence
- From: Journal of Experimental Hematology 2020;28(6):1831-1836
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To investigate the consistency between FCM and PCR on the detecting of MRD in TCF3-PBX1
METHODS:55 cases of paediatric TCF3-PBX1
RESULTS:Among the 55 children with TCF3-PBX1
CONCLUSION:The detection result of MRD in TCF3-PBX1 detect by FCM and PCR shows better consistency. MRD positivity detected by FCM at the end of induction therapy (day 33) predicts a high risk of relapse in TCF3-PBX1 ALL patients.